{"disease":{"id":"vasomotor-symptoms","name":"vasomotor symptoms"},"drugs":{"marketed":[{"drug_id":"conjugated-estrogens-bazedoxifene","indication_name":"Moderate to severe vasomotor symptoms of menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duavee","generic_name":"conjugated-estrogens-bazedoxifene","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"estrogen receptors α and β","drug_class":"Estrogen [EPC]","quality_score":80,"revenue":null,"mechanism":"DUAVEE pairs conjugated estrogens with bazedoxifene, which bind to and activate estrogen receptors α and β."},{"drug_id":"elinzanetant","indication_name":"Moderate to severe vasomotor symptoms due to menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ELINZANETANT","company_name":"","drug_phase":"marketed","molecular_target":"NK1, NK3","drug_class":"","quality_score":55,"revenue":null,"mechanism":"LYNKUET blocks NK1 and NK3 receptors, reducing Substance P and Neurokinin B signaling to modulate neuronal activity in thermoregulation."},{"drug_id":"norethisterone","indication_name":"Vasomotor symptoms associated with climacteric disturbance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"norethisterone","indication_name":"Vasomotor symptoms associated with ovarian deficiency symptoms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"estradiol","indication_name":"Vasomotor symptoms associated with menopausal disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"fezolinetant","indication_name":"Vasomotor symptoms due to menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veozah","generic_name":"FEZOLINETANT","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Neuromedin-K receptor","drug_class":"Neurokinin 3 Receptor Antagonist [EPC]","quality_score":62,"revenue":null,"mechanism":"Veozah works by binding to the Neuromedin-K receptor, which helps to alleviate vasomotor symptoms."},{"drug_id":"menest","indication_name":"Treatment of moderate to severe vasomotor symptoms associated with the menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Menest","generic_name":"Estrogens, Esterified","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Esterified estrogens, sold under the brand names Estratab and Menest, are used for hormone therapy and cancer treatment."},{"drug_id":"estring","indication_name":"Vasomotor symptoms associated with menopausal disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"conjugated-estrogens-bazedoxifene","indication_name":"Treatment of moderate to severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duavee","generic_name":"conjugated-estrogens-bazedoxifene","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"estrogen receptors α and β","drug_class":"Estrogen [EPC]","quality_score":80,"revenue":null,"mechanism":"DUAVEE pairs conjugated estrogens with bazedoxifene, which bind to and activate estrogen receptors α and β."},{"drug_id":"conjugated-estrogens-bazedoxifene","indication_name":"Treatment of moderate to severe vasomotor symptoms associated with menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duavee","generic_name":"conjugated-estrogens-bazedoxifene","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"estrogen receptors α and β","drug_class":"Estrogen [EPC]","quality_score":80,"revenue":null,"mechanism":"DUAVEE pairs conjugated estrogens with bazedoxifene, which bind to and activate estrogen receptors α and β."},{"drug_id":"duavee","indication_name":"Treatment of moderate to severe vasomotor symptoms associated with menopause","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duavee","generic_name":"Bazedoxifene Acetate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Estrogen receptors (ER) α and β","drug_class":"Estrogen agonist/antagonist combination","quality_score":65,"revenue":null,"mechanism":"Pairs conjugated estrogens with bazedoxifene to bind and activate estrogen receptors α and β with tissue-specific effects."}],"pipeline":[],"offLabel":[],"totalMarketed":11,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05083884","title":"A Survey About Hot Flashes in Women Going Through the Menopause","phase":"","overall_status":"COMPLETED","enrollment_count":2176,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT06628388","title":"Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong","phase":"NA","overall_status":"RECRUITING","enrollment_count":1728,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04209543","title":"Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1570,"lead_sponsor_name":"Estetra","has_results":false},{"nct_id":"NCT07490431","title":"An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05300568","title":"A Survey About Trade-offs When Choosing Menopause Treatments","phase":"","overall_status":"COMPLETED","enrollment_count":1465,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT04090957","title":"Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1015,"lead_sponsor_name":"Estetra","has_results":true},{"nct_id":"NCT00535288","title":"Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":946,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00560833","title":"Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":943,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05030584","title":"A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":628,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT00184795","title":"Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":576,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05587296","title":"A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":474,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05033886","title":"A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT05099159","title":"A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05042362","title":"A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":396,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06949553","title":"An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06393673","title":"A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":195,"lead_sponsor_name":"Hansoh BioMedical R&D Company","has_results":false},{"nct_id":"NCT03541200","title":"Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Tanabe Pharma America, Inc.","has_results":true},{"nct_id":"NCT03518138","title":"Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Que Oncology","has_results":false},{"nct_id":"NCT07042516","title":"Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Tioga Pharmaceuticals","has_results":false},{"nct_id":"NCT07408115","title":"Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Bonafide Health","has_results":false},{"nct_id":"NCT05312567","title":"FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Fervent Pharmaceuticals","has_results":false},{"nct_id":"NCT01890109","title":"Study of Erenumab (AMG 334) in Women With Hot Flashes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01015677","title":"A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":99,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04808232","title":"The Effect of Health Education and Progressive Muscle Relaxation Exercise on Vasomotor Symptoms and Sleep Problems With Perimenopausal Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Sidika Pelit Aksu","has_results":false},{"nct_id":"NCT05850338","title":"Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Aylin Güneş","has_results":false},{"nct_id":"NCT06204250","title":"A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07112651","title":"Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"ApexCPG LLC","has_results":false},{"nct_id":"NCT02865538","title":"Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05813067","title":"Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Bonafide Health","has_results":false},{"nct_id":"NCT06219902","title":"A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04981431","title":"A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06957691","title":"Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shehzad Basaria, M.D.","has_results":false},{"nct_id":"NCT05481528","title":"A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05325775","title":"Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Acer Therapeutics Inc.","has_results":true},{"nct_id":"NCT06122181","title":"Study of HS-10384 in Participants of Chinese Postmenopausal Women","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Hansoh BioMedical R&D Company","has_results":false},{"nct_id":"NCT05418426","title":"A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Daré Bioscience, Inc.","has_results":true},{"nct_id":"NCT04903821","title":"A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05071729","title":"A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07335224","title":"Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture","phase":"NA","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Inova Health Care Services","has_results":false},{"nct_id":"NCT04080297","title":"Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Que Oncology","has_results":true},{"nct_id":"NCT05367973","title":"Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Daré Bioscience, Inc.","has_results":true},{"nct_id":"NCT05471817","title":"A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07229404","title":"A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05351892","title":"A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05381142","title":"A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04889287","title":"A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04845841","title":"Comparison of the Extent to Which the Drug Given as Two Different Capsule Sizes Becomes Available to the Body","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05028608","title":"A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05061563","title":"A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT07511660","title":"Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":12,"lead_sponsor_name":"Healing Hope International","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}